Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Liver Cirrhosis, Biliary

• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
• Study of [14C]CS0159 in China Healthy Subjects
• IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA)
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
• A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
• CS0159 in Chinese Patients With PBC (Primary Biliary Cholangitis)
• Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
• Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
• Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
• Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese
• Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
• Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Patients With PBC
• Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis
• Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
• Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
• A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
• Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
• An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
• Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
• A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
• PBC Induced Fatigue Treated With Thiamine
• A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis
• Clinical Research of Reducing Medication Regimen for Ursodeoxycholic Acid in Treatment of Stable Primary Biliary Cholangitis
• RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
• Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
• Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
• Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
• Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Patients With PBC
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
• Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
• Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy
• A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
• Linerixibat Long-term Safety, and Tolerability Study
• Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
• Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus
• Combination Antiretroviral Therapy (cART) for PBC
• A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
• Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis
• Study of OCA Evaluating Pharmacokinetics and Safety in Patients With PBC and Hepatic Impairment
• ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
• Probiotics in PBC Patients of Poor Response to UDCA
• Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine
• A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
• A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
• Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
• Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
• Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.
• Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis
• Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid
• Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis
• Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
• Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis
• Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
• A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
• Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)
• Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis
• Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
• Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
• Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
• Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
• Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
• Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
• The Effect of Bezafibrate on Cholestatic Itch
• Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
• A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
• IBAT Inhibitor A4250 for Cholestatic Pruritus
• An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
• Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
• Pilot Study of FFP104 Dose Escalation in PBC Subjects
• Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Repeat Doses of GSK2330672 Administration in Subjects With Primary Biliary Cirrhosis (PBC) and Symptoms of Pruritus
• Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CT
• Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
• Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis
• Phase 3 Study of Bezafibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
• Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
• Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
• Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
• Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
• Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
• A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
• Pentoxifylline for Primary Biliary Cirrhosis
• Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis
• Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
• Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
• Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
• Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
• Moexipril for Primary Biliary Cirrhosis
• Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
• Use of Fenofibrate for Primary Biliary Cirrhosis
• Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
• Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
• Study of Combivir for Patients With Primary Biliary Cirrhosis
• Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
• Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
• SAMe to Treat Biliary Cirrhosis Symptoms
• Treatment of Cholestatic Pruritus With Sertraline
• Ursodiol-Methotrexate for Primary Biliary Cirrhosis
• Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
• Phase III Randomized Study of Ursodiol With Vs Without Methotrexate for Primary Biliary Cirrhosis
• Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis